Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gray Jodon
Observed names:
G. Jodon,
Jodon, G.
Institution:
Denver Health Medical Center
Observed institutions:
Denver Health Medical Center,
University of Colorado Cancer Center,
University of Colorado Anschutz,
University of Colorado Denver
ORCID:
0009-0007-4828-3790
Observed ORCID:
0009-0007-4828-3790
OpenAlex ID:
A5081260243
Treatment of Urothelial Cancer in Elderly Patients: Focus on Immune Checkpoint Inhibitors
2018
·
Gray Jodon
, Stacy M. Fischer
, et al.
·
Drugs & Aging
·
17
A multi-center analysis of the impact of DA-EPOCH-R dose-adjustment on clinical outcomes of patients with double/triple-hit lymphoma
2022
·
Matthew J. Cortese
, Wei Wei
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
8
Update on multikinase inhibitor therapy for differentiated thyroid cancer
2018
·
Agrawal, V.R.
, Jodon, G.
, et al.
·
Drugs of today
·
7
Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving Anti-CD19 CAR T-cell Therapy
2022
·
Gray Jodon
, Meryl D. Colton
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
·
5
A Multi-Center Analysis of the Impact of Dose Level of R-EPOCH on Outcomes of Patients with Double/Triple-Hit B-Cell Lymphoma
2020
·
Matthew J Cortese
, Wei Wei
, et al.
·
Blood
·
3
The impact of BMI on post-operative survival in bladder cancer patients.
2018
·
Gray Jodon
, Elizabeth Riley Kessler
, et al.
·
Journal of Clinical Oncology
·
2
Chronic diarrhoea and ichthyosis vulgaris: a rare presentation of Hodgkin’s lymphoma
2024
·
Jessica Michelle Allen
, Haley M Simpson
, et al.
·
BMJ Case Reports
·
1
Patterns and Risk of CNS Recurrence after R-EPOCH Treatment for Double/Triple Hit Lymphoma
2020
·
Mohammad Ahsan Sohail
, Hong Li
, et al.
·
Blood
·
1
Rethinking ferritin reference ranges for diagnosing iron deficiency at Denver health
2025
·
Megan Connor
, Nosakhare Osazuwa
, et al.
·
Blood
PDF
Clinical and Radiographic Predictors of Progression and Survival in Relapsed/Refractory Lymphoma Patients Receiving CAR-T Cell Therapy
2021
·
Gray Jodon
, Meryl Colton
, et al.
·
Blood
Clinical and Radiographic Factors Prior to Car T‐cell Therapy Accurately Identify Relapsed/refractory Lymphoma Patients at High Risk for Progression and Poor Survival
2021
·
G. Jodon
, M. D. Colton
, et al.
·
Hematological Oncology
Show more works
View as search
Works count:
11
Citation count:
44
H-index:
4
I10-index:
1
Year
Topic
Type